A generic alternative indicated for Asthma and Breathing. It promotes the relaxation of bronchial muscles to facilitate easier breathing and reduce airway constriction.
A long-acting bronchodilator intended to manage COPD symptoms and designed to alleviate breathlessness to support lung function and mitigate flare-ups.
Mechanism of Action
It blocks muscarinic receptors in the airway muscles, causing them to relax. This keeps the airways open for 24 hours, making breathing easier.
Route of Administration
Inhalation
Onset Time
30 minutes (full effect 1 week)
Duration
24 hours
Contraindications
Allergy to tiotropium, Allergy to ipratropium, Severe milk protein allergy
Severe Adverse Events
Paradoxical bronchospasm, Worsening glaucoma, Urinary retention, Severe allergic reaction
Information for Spiriva is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
